Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
amyotrophic lateral sclerosis
Biotech
Trace uses $101M series A to go after same ALS target as Lilly
Trace Medicine has launched with $101 million and a mission to treat ALS by targeting a protein that recently caught Lilly's attention
James Waldron
Nov 12, 2024 7:00am
Synchron brain-computer interface clears year-long safety study
Oct 2, 2024 10:45am
After Alzheimer's stumble, Athira lays off 70% of workforce
Sep 20, 2024 2:41pm
AI, brain implants reconnect ALS patient with their lost voice
Aug 15, 2024 11:30am
Metagenomi axes ALS program after seeing Biogen and Ionis flop
Aug 14, 2024 9:20am
Amylyx CEOs take hard lessons to rebuild the pipeline
Jul 10, 2024 7:00am
